Warning letter
Medico Labs, Inc.: warning letter of Apr 16, 2007
FDA warning letter UCM076359 · New Jersey District Office
Key facts
| Reference number | UCM076359 |
|---|---|
| Company | Medico Labs, Inc. |
| Subject | CGMP/Deviations/Adulterated |
| Issue date | Apr 16, 2007 |
| Posted date | Apr 16, 2007 |
| Issuing office | New Jersey District Office |
| Product type | Drugs |
| CFR sections cited | 210, 201.66, 211.67, 211.192, 211.194, 201.66(c)(6), 211.68(a), 211.68(b), 211.115(a), 211.166(a), 211.180(e)(1), 211.186(b)(4) and 1 more |
| Country | 3 |
| Inspection city | Congers |
| Inspection ZIP | 10920-1307 |
| Inspection start date | Nov 2, 2006 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: